Amgen (AMGN)

$266.69 1.01 (0.38%)

14:46 EDT AMGN Stock Quote Delayed 30 Minutes

The 3 Most Undervalued Biotech Stocks to Buy in September 2023

By Joel Baglole, InvestorPlace Contributor Sep 12, 2023

While these undervalued biotech stocks have struggled of late, they could surprise investors and prove to be long-term winners.

These Are the ONLY 3 Biotech Stocks to Consider in August 2023

The 3 Best Biotech Stocks to Buy in August

The 3 Most Undervalued Pharma Stocks to Buy Now: July 2023

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 768,168

Day's Range $266.33 - $266.90

52-Week Range $218.44 - $296.67

Dividend & Yield $7.04 (2.64%)

AMGN Stock Predictions, Articles, and Amgen News

From InvestorPlace
From the Web

3 Biotech Stocks for Getting Rich in 2023

By Noah Bolton, InvestorPlace Contributor Jul 18, 2023

These 3 biotech stocks have seen stable or growing revenue this year. This makes them companies to keep on your watchlist.

3 Biotech Stocks That AI Predicts Will Deliver Triple-Digit Returns in 2025

By Chris Markoch, InvestorPlace Contributor Jul 5, 2023

In researching this article, we used AI to help make predictions for potential triple-digit return biotech stocks by 2025

How to Retire Rich: Biotech Stocks Edition

By Josh Enomoto, InvestorPlace Contributor Jun 18, 2023

Thanks to its enormous and practically permanent relevancies, the biotech sector offers a great avenue for retirement planning stocks.

3 Undervalued Biotech Stocks to Buy Before They Blast Off

By Chris Markoch, InvestorPlace Contributor Jun 2, 2023

Fundamental analysis makes these three undervalued biotech stocks to buy plus they have other catalysts that make them compelling.

3 Dogs of the Dow for High-Yield Investors

By Bob Ciura, Sure Dividend May 25, 2023

These Dogs of the Dow boast high dividend yields and will hold up well in a potential recession. Let's take a look.

HZNP Stock Alert: Why Is Horizon Therapeutics Plunging Today

By Larry Ramer, InvestorPlace Contributor May 16, 2023

Horizon Therapeutics (HZNP) stock is sinking after the FTC reportedly decided to sue to block its merger with Amgen (AMGN).

7 Blue-Chip Stocks to Buy in May 2023

By Josh Enomoto, InvestorPlace Contributor May 4, 2023

While not the most exciting sector available, rising fears in the market incentivizes the best blue-chip stocks to buy.

7 Dividend Stocks to Buy That Are Backed by Strong Cash Flows

By Chris Markoch, InvestorPlace Contributor Apr 16, 2023

Cash is king and this article highlights seven dividend stocks with strong cash flows and an emphasis on free cash flow

3 Must-Buy Dow Stocks for Your April Buy List

By Alex Sirois, InvestorPlace Contributor Apr 5, 2023

The range of Dow stocks to choose from is small, but there are plenty of great opportunities for investors to choose from.

7 Over-$100 Stocks That Are Worth Every Penny

By Louis Navellier and the InvestorPlace Research Staff Mar 3, 2023

To get most of the best-known stocks, you have to be prepared to pay at least $100 per share. Here are seven stocks to buy.

Why Billionaires Paul Tudor Jones and George Soros Bought Up Horizon (HZNP) Stock

By Larry Ramer, InvestorPlace Contributor Feb 15, 2023

Two well-regarded billionaire investors -- George Soros and Paul Tudor Jones -- bought Horizon (HZNP) stock last quarter.

The 7 Most Undervalued Dow Stocks to Buy in February 2023

By Josh Enomoto, InvestorPlace Contributor Feb 2, 2023

If you’re looking for the best deals among the most iconic enterprises, these are the most undervalued Dow stocks to buy.

Amgen Layoffs 2023: What to Know About the Latest AMGN Job Cuts

By Shrey Dua, InvestorPlace Assistant News Writer Jan 30, 2023

Wall street is buzzing over Amgen layoffs today. The biotech company announced it laid off 300 of its U.S. employees.

Dogs of the Dow 2023: 5 Dividend Stocks for Income Investors

By Prakash Kolli Jan 24, 2023

The 2023 Dogs of the Dow feature several stocks investors should consider for their income portfolios. Here are the top five picks.

5 Top Pharma Stocks of 2022 to Buy for the Long Haul

By Dana Blankenhorn, InvestorPlace Contributor Jan 6, 2023

The biggest drug company blockbusters bring in billions of dollars, which is one of the reasons to consider these top Pharma stocks.

The 10 Best Dividend Stocks of All Time

By Will Ashworth, InvestorPlace Contributor Jan 4, 2023

The best dividend stocks of all time are some of the best-appreciating stocks over the past decade and should be on your watchlist in 2023.

The 7 Best Retirement Stocks to Buy Now

By Louis Navellier and the InvestorPlace Research Staff Dec 18, 2022

Current bear market conditions present the perfect opportunity to invest in retirement stocks while they're trading at bargain valuations.

Horizon Therapeutics (HZNP) Stock Pops on HUGE Amgen Deal

By Joel Baglole, InvestorPlace Contributor Dec 12, 2022

HZNP stock is up on news that Horizon Therapeutics is being bought by Amgen in a friendly deal that's positive for both companies.

7 Christmas Stocks to Buy for Happy Holidays

By Louis Navellier and the InvestorPlace Research Staff Dec 5, 2022

2022 took a toll on a lot of portfolios, leaving many investors feeling more like a Grinch than looking for Christmas stocks to buy.

7 Top-Tier Dividend Stocks to Buy for 2023

By Louis Navellier and the InvestorPlace Research Staff Nov 18, 2022

You can find great top-tier dividend stocks in a variety of sectors. These are some of the best names you can buy heading into 2023.

Amgen (AMGN)

The 3 Most Undervalued Biotech Stocks to Buy in September 2023

These Are the ONLY 3 Biotech Stocks to Consider in August 2023

The 3 Best Biotech Stocks to Buy in August

The 3 Most Undervalued Pharma Stocks to Buy Now: July 2023

11 Best Stocks to Buy for 2023

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Amgen (AMGN)

11 Best Stocks to Buy for 2023

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

AMGN Stock Predictions, Articles, and Amgen News

Subscriber Sign in